All testing information and descriptions are directly from the company websites. All information is promoted for educational purposes. Arizona Lyme Disease Association does not partner or get paid by any laboratory.
For over 30 years, IGeneX has been the global leader in the research and development of tests that accurately detect Lyme disease, Relapsing Fever, and other tick-borne diseases. Tick-borne illnesses can affect every part of your life, and without effective diagnosis and treatment, symptoms can often worsen and progress into severe and even life-threatening health issues. And when you can’t find the cause or a way to get better, your quality of life suffers. At IGeneX, we make it our singular mission to offer best-in-class testing for tick-borne diseases that delivers the most comprehensive and accurate results possible, so you can find the right treatment path to restore your health and get back to enjoying your life.
The Vibrant Immunochip is made from recombinant proteins of several species of Borrelia burgdorferi, and not just from B31 used by other western blot tests. Vibrant criteria for detection has higher sensitivity and specificity than the two-tier testing by CDC criteria, as demonstrated by internal studies. This eliminates doubt for clinicians.
The Vibrant Tickborne Diseases panel is the first of its kind to be run on a silicon micro-array platform, providing the highest level of specificity and sensitivity in the industry for detecting tickborne diseases.
Patients often present with a range of non-specific symptoms that may be Lyme, or other conditions that have symptom overlap. Patients with diagnosed Lyme may also experience resurgence of symptoms, which might suggest co-infections. Co-infections are complex and should be included in an initial screen of Lyme and related illnesses.
Vibrant has the most comprehensive antibody (indirect) and DNA (direct) test for detection of Lyme and co-infections that, in most cases, can assist the clinician in assessing these situations and lead to the correct diagnosis.
Because standard treatment for tickborne diseases usually involves courses of antibiotics that are prolonged, this can also leave the patient at risk for multiple chronic inflammatory symptoms or conditions due to impact to the microbiome. It is recommended that patients being treated for tickborne diseases undergo regular microbiome screening during antibiotic therapy, such as the Vibrant Gut Zoomer or Vibrant Gut Pathogens tests.
The DNA ConneXions® Lyme Disease Test Panel tests for four different genes that are found in Borrelia burgdorferi, the most common cause of Lyme disease in the United States, and ten common Lyme disease vector born co-infectors and other organisms including Borrelia recurrentis, Borrelia miyamotoi, Babesia microti, Babesia divergens, Babesia duncani, Bartonella bacilliformis, Ehrlichia chaffensis, Bartonella henselae, Bartonella quintana, and Anaplasma phagocytophilum.
Positive detection of Lyme co-infectors indicates likely infection with the Lyme spirochete as well.
At Fry Laboratories, LLC, we have combined our own sophisticated bioinformatics data analysis software and our proprietary library preparation chemistry for Next Generation DNA sequencing to form the Rapid Infectious Disease Identification (RIDI™) system. This system detects and identifies organisms in clinical samples by sequencing DNA isolated directly from patient samples and running it through our analysis software. RIDI™ analyzes each individual sequence read by comparing it to the National Center for Biotechnology Information (NCBI) databases of all known organisms and finds the best match. Each sequence read must pass quality control criteria to ensure reliable results. We also have additional thresholding values to make sure the results are consistent with actual organisms rather than environmental or background detection events. The RIDI™ system compiles these identification results into a clinical report that is easy for physicians to read and understand.
R.E.D. Laboratories is a private Belgian company, focused on developing and performing specialty research and diagnostic tests for chronic immune disorders, intestinal dysfunctions, tick-borne diseases (Lyme disease) and multifactorial disorders like autism and CFS.
Phages belong to the simplest and most primitive form of life (viruses). They are extraordinarily specific for the bacterial host that they infect to propagate. They can rapidly infect their host and insert its genetic material into their host. As a result, they produce large numbers of copies that can further infect (and in some specific cases decimate) the bacteria causing the infection. They can also make the bacteria vulnerable to classic treatment by altering their genetic material. Most importantly, bacteriophages can have a killing capacity. Phages are so small that they can penetrate and eventually disrupt bacterial biofilms. Such biofilms are a major barrier employed by bacteria against antibiotics and hence an important contributor to antibiotic resistance. Phages ability to penetrate biofilms allows them to propagate to high levels in the localized centers of bacterial infection and to destroy the bacteria within them, to produce strong, but highly localized, therapeutic effect.
Bacteriophages are ubiquitous and are part of the natural ‘ecosystem’ of the bacteria living and replication cycles. We have decided to focus on bacteriophages as a target for direct detection of an infection, as they are specific and outnumber the pathogen bacterial population.
Infectolab Americas is a CLIA certified laboratory located in Oakdale, Minnesota. We specialize in comprehensive lab testing for tick-borne infections and other infectious disease testing. We provide tools for Health Care Practitioners to monitor and manage infection driven illnesses.
Our goal is to provide an unparalleled laboratory service throughout the United States. We strive to engage with doctors and researchers to create resources and support networks that are so important for those suffering from infection driven illnesses.
Our focus is on delivering a quality laboratory performance and guaranteeing a superior sample output; this includes quick overnight shipment and a rapid turnaround time, as well as providing the most accurate laboratory results possible.